Investing in ai for research has become a strategy-level choice for enterprises to build their core competitiveness in the future. A report by the McKinsey Global Institute shows that enterprises that fully apply artificial intelligence in research and development have their product innovation cycles shortened by an average of 40% and their R&D efficiency increased by up to 30%. For example, in the pharmaceutical industry, Astrazeneca utilized the ai for research platform to reduce the discovery time of new drug targets from the traditional five years to nine months, increasing the success rate by 15%. As a result, an anti-cancer drug entered the clinical trial stage 18 months ahead of schedule in 2023. This is not only about speed. Boston Consulting Group’s analysis indicates that enterprises that deeply integrate AI into their R&D processes have an average increase of 20 percentage points in their return on R&D investment, while reducing R&D budget waste by 25%, and precisely directing more resources towards high-potential projects.
From materials science to consumer electronics, ai for research is redefining possibilities. Huawei has deployed AI simulation models in its communication technology research and development, reducing the simulation computing time for exploring key 6G technologies by 70% and saving hundreds of millions of yuan in trial-and-error costs annually. Similarly, BMW Group utilized AI-driven generative design to evaluate over 100,000 lightweighting solutions for automotive parts within a year. Eventually, it reduced the weight of a certain part by 35% while increasing its strength by 20%. These are not isolated cases. According to Deloitte’s research on the world’s top 500 companies, companies that use AI for market and consumer behavior analysis have a 38% increase in the success rate of new product launches, and the accuracy of early customer satisfaction predictions has reached 85%, significantly reducing the risk of market failure. This has been repeatedly verified in the fast-moving consumer goods industry, such as Procter & Gamble’s new product incubation.
In addition to direct economic benefits, AI research capabilities serve as a key buffer for enterprises to deal with systemic risks. During the global chip shortage crisis that began in 2021, TSMC increased its mature process capacity by 10% with its advanced AI manufacturing process optimization system, effectively alleviating supply chain pressure. In the field of climate change, the Danish energy company Ørsted utilized the ai for research model to optimize the layout of offshore wind farms, reducing the prediction error of annual power generation from 8% to 3% and increasing the average return rate of the project by 2.5%. The World Economic Forum points out that enterprises that apply AI to sustainable research and development have a 40% lower probability of being chronically impacted by environmental regulations and are more likely to obtain green financing incentives ranging from 15% to 30% of their total investment.
Ultimately, the value of this kind of investment lies in the exploration of unknown territories. Google DeepMind’s AlphaFold2 has solved the problem of protein structure prediction, compressing decades of human work into just a few days. This has directly led to the free opening of over one million protein structure databases and accelerated global biomedical innovation. Looking ahead, PWC predicts that by 2030, AI will contribute an additional 15.7 trillion US dollars to the global economy, with nearly 40% coming from product enhancement and innovation. Therefore, deeply integrating AI into the R&D system has risen from a “tool for enhancing efficiency” to a “strategy for survival”. It not only endows enterprises with higher profit margins and faster speeds, but also the core ability to predict and define the future.